首页> 外文OA文献 >Intrastromal Corneal Ring Segment Implantation (Keraring 355°) in Patients with Central Keratoconus: 6-Month Follow-Up
【2h】

Intrastromal Corneal Ring Segment Implantation (Keraring 355°) in Patients with Central Keratoconus: 6-Month Follow-Up

机译:中央角蛋白的患者中,科罗拉多菌患者的科内角膜环段植入(Keraring 355°):6个月的随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We evaluate the efficacy and safety of Keraring 355° intrastromal corneal ring segment (ICRS) implantation aided by PocketMaker microkeratome for the correction of keratoconus. Patients underwent ICRS insertion using mechanical dissection with PocketMaker microkeratome and completed 6 months of follow-up. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refraction, topographic findings, safety, efficacy index, and adverse events were reported for six months postoperatively. We evaluated 15 eyes of 15 patients (12 men) with a mean age of 28.87 ± 6.94 years (range 21–49 years). At final postoperative examination, there was a statistically significant reduction in the spherical equivalent refractive error compared to preoperative measurements (−5.46 ± 1.52 to −2.01 ± 1.63 D, P< 0.001). Mean preoperative UCVA (logMAR) before implantation was 0.79 ± 0.48, and postoperative UCVA was 0.28 ± 0.15, P= 0.001. Mean preoperative BSCVA (logMAR) before implantation was 0.36 ± 0.21; at final follow-up examination BSCVA was 0.18 ± 0.9, P= 0.009. Mean K decreased from 48.33 to 43.31 D, P< 0.001. All patients were satisfied with ICRS implantation; 86.7% were moderately to very happy with the results. No intraoperative or postoperative complications were demonstrated. This preliminary study shows that ICRS (Keraring 355°) implantation is an efficient, cost-effective, and minimally invasive procedure for improving visual acuity in nipple type keratoconic corneas.
机译:我们评估了Keraring 355°内耳术的疗效和安全性通过口袋制剂微观辅助KeratoConus矫正了Keratoconus的矫正。患者接受了ICRS使用与口袋制剂微立角组织的机械解剖插入,并完成了6个月的随访。未经校正的视力(UCVA),最佳景观校正的视力(BSCVA),折射,地形结果,安全性,疗效指数和不良事件术后六个月报告。我们评估了15名患者(12名男性)的15只眼睛,平均年龄为28.87±6.94岁(21-49岁)。在最终术后检查时,与术前测量相比,球形当量折射误差有统计显着降低(-5.46±1.52至-2.01±1.63d,p <0.001)。植入前的平均术前UCVA(Logmar)为0.79±0.48,术后UCVA为0.28±0.15,P = 0.001。植入前的平均术前BSCVA(Logmar)为0.36±0.21;在最终后续检查中,BSCVA为0.18±0.9,p = 0.009。平均k从48.33降至43.31d,p <0.001。所有患者对ICRS植入感到满意; 86.7%适度,对结果非常满意。没有证明术中或术后并发症。该初步研究表明,ICRS(KERARING 355°)植入是一种有效,经济效益和微创手术,用于改善乳头型角灭绝角膜中的视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号